Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

• Main Authors: G. Adami (Author), L. Idolazzi (Author), C. Benini (Author), E. Fracassi (Author), A. Carletto (Author), O. Viapiana (Author), D. Gatti (Author), M. Rossini (Author), A. Fassio (Author)
• Format: Book
• Published: PAGEPress Publications, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Psoriatic arthritis (PsA) is an inflammatory disease characterized by peripheral and axial involvement. Biological disease-modifying antirheumatic drugs (bDMARDs) are the mainstream treatment for PsA and bDMARDs retention rate is a proxy for the drug's overall effectiveness. However, it is uncl...